
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Aldehyde dehydrogenase 4-A1/P5CDH/ALDH4A1 CRISPR/Cas9 KO Plasmid (m) | sc-431814 | 20 µg | $397.00 |
Mouse Aldh4a1 encodes aldehyde dehydrogenase 4-A1 (P5CDH/ALDH4A1), a mitochondrial enzyme that catalyzes conversion of Δ1-pyrroline-5-carboxylate to glutamate in the terminal steps of proline and hydroxyproline catabolism. By controlling the flux between proline metabolism, glutamate production, and mitochondrial redox balance, ALDH4A1 influences amino acid homeostasis and reactive aldehyde detoxification. Perturbation of this pathway is linked to altered oxidative stress handling and mitochondrial dysfunction, making Aldh4a1 a useful node for studying metabolic stress responses. ALDH4A1 activity also connects to broader nutrient-sensing and anaplerotic processes via glutamate-dependent entry into the TCA cycle.
Aldehyde dehydrogenase 4-A1/P5CDH/ALDH4A1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Aldh4a1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Aldh4a1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Aldh4a1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Aldehyde dehydrogenase 4-A1/P5CDH/ALDH4A1 protein expression.
This CRISPR knockout system enables efficient generation of Aldh4a1-deficient cell models for investigation of Aldehyde dehydrogenase 4-A1/P5CDH/ALDH4A1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.